AI in drug discovery

News

Industry steps up as EU debates an action plan for AI

Corporations, investment groups, and technology providers have teamed up in a new project that aims to "unlock Europe's full potential" in AI.

News

Bioptimus raises $41m for its GenAI model for biology

AI startup Bioptimus takes its funding above $76m as it prepares for the launch of a universal foundation model for pathology later this year.

News

AMD shadows NVIDIA with a move into AI drug discovery

Chipmaker AMD has taken a 20% stake in Absci, a specialist in the use of artificial intelligence in for biologic drug discovery.

News

Novo Nordisk swells alliance with AI firm Valo Health

Novo Nordisk almost doubles the scale of its R&D alliance with AI specialist Valo Health, which now spans 20 programmes and a value of up to $4.6bn.

News

Valo Health chief executive Brian Alexander, who is also CEO-Partner of Flagship Pioneering

Flagship-backed AI startup Valo shelves eye disease drug

Valo Health will no longer develop its ROCK1/2 inhibitor for diabetic retinopathy on its own after a trial readout but will seek to partner the drug.

R&D

The AI revolution in pharma

The pharmaceutical industry is at a pivotal moment. Artificial intelligence (AI) is shifting from improving processes to reshaping disease treatment and care delivery.

Industry steps up as EU debates an action plan for AI

Bioptimus raises $41m for its GenAI model for biology

AMD shadows NVIDIA with a move into AI drug discovery

Novo Nordisk swells alliance with AI firm Valo Health

Flagship-backed AI startup Valo shelves eye disease drug

The AI revolution in pharma

Remepy's hybrid Parkinson's therapy poised for phase 3

Discover a new era of healthcare panel engagement: Grounded ...

AI in drug discovery

Editor's Picks